Global Diarrhea Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Diarrhea Market was valued at $10.9 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.1% CAGR, to an estimated market size of $14.0 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global diarrhea market encompasses the prevention, diagnosis, and therapeutic management of acute and chronic diarrheal conditions. The scope includes Oral Rehydration Solutions (ORS), pharmacological treatments such as antimotility agents, antibiotics, and adsorbents, as well as probiotics and zinc supplements. It excludes general surgical procedures but includes specialized management for traveler's diarrhea, chemotherapy-induced diarrhea, and infectious gastrointestinal syndromes.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Diarrhea Market in the period 2025-30:
- There is a significant shift toward non-antibiotic therapies and microbiome-based solutions due to rising concerns over antimicrobial resistance.
- The aging global population is emerging as a critical demographic driver, with a nearly 200% increase in incidence observed among older adults in recent decades.
- Integration of digital health tools and AI-based symptom checkers is facilitating earlier diagnosis and improving patient adherence to rehydration protocols.
- Expansion of over-the-counter (OTC) availability and self-medication trends are driving volume growth in emerging economies with improving pharmacy networks.
- Increased international tourism to high-risk tropical regions is fueling the demand for specialized traveler's diarrhea prophylactic and rescue treatments.
- Public health initiatives by organizations like WHO and UNICEF continue to mandate the use of low-osmolarity ORS and zinc as the gold standard for pediatric care.
- Advancements in rapid diagnostic tests are allowing for more precise identification of viral versus bacterial pathogens, reducing the unnecessary use of antibiotics.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- Asia-Pacific
- North America
- Europe
- Rest of World
Segments
- Oral Rehydration Solutions (ORS)
- Antidiarrheal Drugs
- Antibiotics
- Probiotics & Supplements